CSF2 and myalgic encephalomeyelitis/chronic fatigue syndrome: In our experience, the use of G-CSF or granulocyte macrophage colony-stimulating factor (GM-CFS), at a mean dose of 300 μcg/day, was also useful in life-threatening idiosyncratic drug-induced agranulocytosis in the elderly [3,6,15].